Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
Public ClinicalTrials.gov record NCT03636256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1/2 Trial Evaluating the Safety and Tolerability of NanoDoce® Injection and Intravesical Instillation in Subjects With Urothelial Carcinoma
Study identification
- NCT ID
- NCT03636256
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- NanOlogy, LLC
- Industry
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Interventions
- NanoDoce (direct injection) Drug
- NanoDoce (intravesical instillation) - Visit 2 Instillation Drug
- Institutional Standard of Care Other
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2019
- Primary completion
- Nov 1, 2021
- Completion
- Nov 1, 2021
- Last update posted
- Aug 13, 2023
2019 – 2021
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| BCG Oncology, PC | Phoenix | Arizona | 85032 | — |
| James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions | Baltimore | Maryland | 21287 | — |
| Columbia University Herbert Irving Comprehensive Cancer Center | New York | New York | 10032 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| UT Health San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03636256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03636256 live on ClinicalTrials.gov.